Back
First Trust Nasdaq Pharmaceuticals ETF Vs. Virtus LifeSci Biotech Products ETF Industry Stock Comparison
Sell
37
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
27.74
Seasonality Move:
3.41%
Buy
58
BBP
Virtus LifeSci Biotech Products ETF
Last Price:
60.93
Seasonality Move:
4.95%
Sell
37
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $27.78. The Score for FTXH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Virtus LifeSci Biotech Products ETF (BBP)
is a Buy
Is Virtus LifeSci Biotech Products ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Products ETF [BBP] share price is $62.06. The Score for BBP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $27.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBP Stock Price Chart
What is Virtus LifeSci Biotech Products ETF's stock price today?
-
The Virtus LifeSci Biotech Products ETF share price today is $62.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBP is experiencing selling pressure, which indicates risk of future bearish movement.
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 43.79 | Sell |
Chaikin Money Flow: | 6508 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.65 - 28.77) | Sell |
Bollinger Bands (100): | (27.91 - 29.17) | Sell |
BBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 42.27 | Sell |
Chaikin Money Flow: | -9611 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.08 - 66.2) | Sell |
Bollinger Bands (100): | (60.95 - 64.71) | Sell |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.71 | Buy |
20-day SMA: | 28.16 | Sell |
50-day SMA: | 28.53 | Sell |
200-day SMA: | 27.84 | Sell |
8-day EMA: | 27.71 | Buy |
20-day EMA: | 28.06 | Sell |
50-day EMA: | 28.34 | Sell |
200-day EMA: | 27.87 | Sell |
BBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.12 | Sell |
20-day SMA: | 64.39 | Sell |
50-day SMA: | 63.51 | Sell |
200-day SMA: | 59.77 | Buy |
8-day EMA: | 62.82 | Sell |
20-day EMA: | 63.69 | Sell |
50-day EMA: | 63.45 | Sell |
200-day EMA: | 60.19 | Buy |
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Products ETF Earnings Growth & BBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Virtus LifeSci Biotech Products ETF Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |